Robert E. Landry
2021
In 2021, Robert E. Landry earned a total compensation of $8.3M as Executive Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,052,182 |
|---|---|
| Option Awards | $3,839,805 |
| Salary | $822,800 |
| Stock Awards | $2,559,468 |
| Other | $24,200 |
| Total | $8,298,455 |
Landry received $3.8M in option awards, accounting for 46% of the total pay in 2021.
Landry also received $1.1M in non-equity incentive plan, $822.8K in salary, $2.6M in stock awards and $24.2K in other compensation.
Rankings
In 2021, Robert E. Landry's compensation ranked 1,380th out of 12,405 executives tracked by ExecPay. In other words, Landry earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,380 out of 12,405 | 89th |
Division Manufacturing | 496 out of 5,494 | 91st |
Major group Chemicals And Allied Products | 180 out of 2,369 | 92nd |
Industry group Drugs | 150 out of 2,090 | 93rd |
Industry Pharmaceutical Preparations | 99 out of 1,537 | 94th |
Source: SEC filing on April 21, 2022.
Landry's colleagues
We found five more compensation records of executives who worked with Robert E. Landry at Regeneron Pharmaceuticals in 2021.
2021
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
2021
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2021
Joseph LaRosa
Regeneron Pharmaceuticals
General Counsel
2021
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2021
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019